Predicted risk of INR ≥ 4.5 ...
{{ model.survival.PITTitle }}
{{ model.survival.YNETitle }}
Predicted risk of INR ≥ 4.5
Outcome stratification
Conditional information
Result interpretation
The prediction model can help physicians to identify patients at the lower spectrum of thromboembolic risk and those for whom the risk of bleeding during vitamin K antagonist (VKA) therapy is high. Using the prediction model may also help
when counselling and informing patients about their potential risk for haemorrhage while on anticoagulants, and in identifying those patients who might benefit from more careful management of anticoagulation. Alternatively, these patients can also be switched to direct oral anticoagulants (DOACs), which cause less major bleeding, such as intracranial haemorrhages, compared to VKAs
Calculations alone should never dictate patient care, and are no substitute for professional judgement. See our full disclaimer.
Model feedback
No feedback yet 1 Comment {{ model.comments.length }} Comments
Please sign in to enable Evidencio print features
If you don't have an Evidencio Community Account you can create your free personal account at:
https://www.evidencio.com/registration
Printed results - Examples {{ new Date().toLocaleString() }}

Evidencio Community Account Benefits
With an Evidencio Community account you can:
- Create and publish your own prediction models.
- Share your prediction models with your colleagues, research group, organization or the world.
- Review and provide feedback on models that have been shared with you.
- Validate your models and validate models from other users.
- Find models based on Title, Keyword, Author, Institute, or MeSH classification.
- Use and save prediction models and their data.
- Use patient specific protocols and guidelines based on sequential models and decision trees.
- Stay up-to-date with new models in your field as they are published.
- Create your own lists of favorite models and topics.
A personal Evidencio account is free, with no strings attached!
Join us and help create clarity, transparency, and efficiency in the creation, validation, and use of medical prediction models.
{{ variable.title }}
{{ row }} |